Abstract
The feasibility of surface enhanced Raman spectroscopy (SERS) for multiple myeloma (MM) detection is investigated in this work. SERS measurements of silver nanoparticle mixed blood plasma samples are performed using a low-cost and portable Raman spectrometer. The tentative assignment of Raman peaks indicates an increase in amino acids, nucleic acid base content and a decrease in cholesterol ester in the MM group. Combined with the multivariate analysis method of principle component analysis (PCA) and linear discriminate analysis (LDA), a diagnosis result for 32 samples with a sensitivity of 93.75% and specificity of 87.5% is achieved. The performance of the corresponding receiver operating characteristic (ROC) curve is 0.957. It is a potential rapid and non-invasive method for preliminary MM screening.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
